← Open Payments lookup

STEPHEN PENEPACKER: Open Payments

NPI 1336165125 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,571 in 83 payments from 10 companies in 2025. Trend: 2023 $399 · 2024 $1,226 · 2025 $1,571

Food & beverage: $1,528Education: $43
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$287
ABBVIE INC.17$243
Alkermes, Inc.9$229
E.R. Squibb & Sons, L.L.C.19$229
Teva Pharmaceuticals USA, Inc.6$152
Lundbeck LLC7$145
Otsuka America Pharmaceutical, Inc.6$124
Janssen Pharmaceuticals, Inc4$119
Almatica Pharma LLC1$23
Axsome Therapeutics, Inc.1$21

Products named: CAPLYTA, VRAYLAR, ARISTADA, COBENFY, ABILIFY ASIMTUFII, UZEDY, INVEGA SUSTENNA, REXULTI.

Industry payments across CA — which companies pay providers there.